Long-term intrapatient evolution during HIV-2 infection
نویسندگان
چکیده
منابع مشابه
Population genomics of intrapatient HIV-1 evolution
Many microbial populations rapidly adapt to changing environments with multiple variants competing for survival. To quantify such complex evolutionary dynamics in vivo, time resolved and genome wide data including rare variants are essential. We performed whole-genome deep sequencing of HIV-1 populations in 9 untreated patients, with 6-12 longitudinal samples per patient spanning 5-8 years of i...
متن کاملThe Evolution of Long-term Care Programs; Comment on “Financing Long-term Care: Lessons From Japan”
The need for long-term care (LTC) represents a “new social risk,” one that overlaps with and complements systems of care that pre-date such programs, complicating LTC program design. This commentary expands on Ikegami’s discussion of how these structural factors must be accommodated, as well as historical and cultural factors that influence public expectations of such a...
متن کاملLong-Term Evolution of a Long-Term Evolution Model
HANSON, H. and KRAUS, N.C., 2011. Long-Term Evolution of a Long-Term Evolution Model. In: Roberts, T.M., Rosati, J.D., and Wang, P. (eds.), Proceedings, Symposium to Honor Dr. Nicholas C. Kraus, Journal of Coastal Research, Special Issue, No. 59, pp. 118-129. West Palm Beach (Florida), ISSN 0749-0208. This paper reviews the 25-plus year history of significant developments of the GENESIS shoreli...
متن کاملOn the modeling of long-term HIV-1 infection dynamics
In this paper we propose and study models of long-term Human Immunodeficiency Virus (HIV-1) infection. Our aim is to identify model mechanisms that allow to explain the trends observed in clinical measurements of the number of CD4+ Tcells and virus throughout the long-term HIV-1 infection, from the acute phase until the onset of AIDS. To achieve our goal we apply some standard methods of modeli...
متن کاملTemporary Treatment during Primary HIV Infection Does Not Affect Virologic Response to Subsequent Long-Term Treatment
Temporary cART during primary HIV-infection (PHI) did not select for drug resistance mutations after treatment interruption and did not affect the subsequent virological response to long-term cART. Our data demonstrate that fear of drug resistance development is not a valid argument to refrain from temporary early treatment during PHI.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Retrovirology
سال: 2006
ISSN: 1742-4690
DOI: 10.1186/1742-4690-3-s1-p38